Literature DB >> 17882407

Drug-related risks.

Ulrich Klotz.   

Abstract

Mesh：

Year:  2007        PMID： 17882407     DOI： 10.1007/s00228-007-0383-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  Analysis of the direct cost of adverse drug reactions in hospitalised patients.

Authors:  R Bordet; S Gautier; H Le Louet; B Dupuis; J Caron
Journal:  Eur J Clin Pharmacol       Date:  2001-03       Impact factor: 2.953

Review 2.  Which drugs cause preventable admissions to hospital? A systematic review.

Authors:  R L Howard; A J Avery; S Slavenburg; S Royal; G Pipe; P Lucassen; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2006-06-26       Impact factor: 4.335

3.  Rosiglitazone--continued uncertainty about safety.

Authors:  Jeffrey M Drazen; Stephen Morrissey; Gregory D Curfman
Journal:  N Engl J Med       Date:  2007-06-05       Impact factor: 91.245

4.  The record on rosiglitazone and the risk of myocardial infarction.

Authors:  Bruce M Psaty; Curt D Furberg
Journal:  N Engl J Med       Date:  2007-06-05       Impact factor: 91.245

5.  Rosiglitazone and cardiotoxicity--weighing the evidence.

Authors:  David M Nathan
Journal:  N Engl J Med       Date:  2007-06-05       Impact factor: 91.245

6.  FDA places "black box" warning on antidiabetes drugs.

Authors:  Janice Hopkins Tanne
Journal:  BMJ       Date:  2007-06-16

7.  Risk assessment and comparisons: an introduction.

Authors:  R Wilson; E A Crouch
Journal:  Science       Date:  1987-04-17       Impact factor: 47.728

8.  Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.

Authors:  Gunnar H Gislason; Søren Jacobsen; Jeppe N Rasmussen; Søren Rasmussen; Pernille Buch; Jens Friberg; Tina Ken Schramm; Steen Z Abildstrom; Lars Køber; Mette Madsen; Christian Torp-Pedersen
Journal:  Circulation       Date:  2006-06-19       Impact factor: 29.690

9.  Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

Authors:  Bo Lagerqvist; Stefan K James; Ulf Stenestrand; Johan Lindbäck; Tage Nilsson; Lars Wallentin
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

10.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Authors:  Steven E Nissen; Kathy Wolski
Journal:  N Engl J Med       Date:  2007-05-21       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.